首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biomaterials

缩写:BIOMATERIALS

ISSN:0142-9612

e-ISSN:1878-5905

IF/分区:13.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引12839
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Bang Liu,Jinghang Li,Ming Li Bang Liu
Fluorescence biosensing offers a promising transformative strategy for non-invasively diagnosing diseases, but its deployment for clinical urinalysis is largely hindered by the lack of fluorescent endogenous biomarkers, insufficient detecti...
MiriGuli Musa,Jianbin Shi,Yupeng Wang et al. MiriGuli Musa et al.
Surgical resection inadvertently promotes metastasis via platelet activation and tumor cell-platelet aggregation. Conventional postoperative therapies fail to address this early pro-metastatic window and lack precise local modulation. Herei...
Zhongqing Sun,Jie Zhao,Jia Li et al. Zhongqing Sun et al.
Ischemic stroke remains a leading cause of long-term disability worldwide, and existing therapies have a very limited capacity to repair lost neurons or restore brain function. This review examines how biomaterial-enhanced stem cell therapi...
Ziqi Guo,Xianyan Liang,Haoran Ding et al. Ziqi Guo et al.
The immunosuppressive tumor microenvironment (TME) in non-small cell lung cancer (NSCLC), particularly the dominance of myeloid-derived suppressor cells (MDSCs), remains a major barrier to effective immunotherapy. Here, we developed a bioen...
Susu Zhang,Wuming Hu,Tao Wang et al. Susu Zhang et al.
Diabetic cardiomyopathy (DbCM), a severe complication of type 2 diabetes mellitus (T2DM), is driven by glucolipid metabolism dysregulation-induced oxidative stress and ferroptosis. Current clinical management, primarily relying on glucose-l...
Weihong Nie,Tongxiao Luan,Chengxun Liu et al. Weihong Nie et al.
Triple-negative breast cancer (TNBC) remains a significant clinical challenge due to the lack of actionable targets, dose-limiting cardiotoxicity, and the limited efficacy of single-modality therapies. Doxorubicin (DOX), a first-line chemot...
Han Xu,Fangmian Wei,Mengjie Hou et al. Han Xu et al.
Sonodynamic therapy is expected to induce pyroptosis of cancer cells and activate the immune response. However, its efficacy is limited by the tumor hypoxic microenvironment. Moreover, these sonosensitizers trigger a gasdermin D palmitoylat...
Jingtian Zhang,Zhaoyun Liu,Yajing Jiang et al. Jingtian Zhang et al.
Tumor glycolysis supports malignant progression and promotes an immunosuppressive microenvironment, but glycolysis blockade alone often gives limited therapeutic benefit because tumor cells can adapt metabolically and metabolic inhibition d...
Ying Gong,Jie Yan,Yuhe Yang et al. Ying Gong et al.
Central nervous system lymphoma (CNSL) is difficult to treat owing to the blood-brain barrier and limited efficacy of conventional chemotherapy. Herein, we report a bioinspired cisplatin-based nanomedicine that exploits gut-derived macropha...
Shue Jin,Jidong Li,Zongke Zhou et al. Shue Jin et al.
Bone defects caused by trauma, infection, or tumor removal are often combined with soft tissue injury. This creates a major clinical problem because there are no effective methods to repair both hard and soft tissues at the same time. This ...